Na,K-ATPase activity promotes macropinocytosis in colon cancer via Wnt signaling

Author:

Tejeda-Muñoz Nydia123ORCID,Azbazdar Yagmur1,Sosa Eric A.4ORCID,Monka Julia1,Wei Pu-Sheng5,Binder Grace1,Mei Kuo-Ching5ORCID,Kurmangaliyev Yerbol Z.6,De Robertis Edward M.1

Affiliation:

1. David Geffen School of Medicine, University of California 1 Department of Biological Chemistry , , Los Angeles 90095-1662 , USA

2. University of Oklahoma Health Sciences Center 2 Department of Oncology Science , , Oklahoma City, OK 73104 , USA

3. OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center 3 , Oklahoma City, OK 73104 , USA

4. Albert Einstein College of Medicine 4 Department of Genetics , , Bronx, NY 10461 , USA

5. School of Pharmacy and Pharmaceutical Sciences, State University of New York at Binghamton 5 Department of Pharmaceutical Sciences , , Binghamton, Johnson City, NY 13790 , USA

6. Brandeis University 6 Department of Biology , , Waltham, MA 02453 , USA

Abstract

ABSTRACT Recent research has shown that membrane trafficking plays an important role in canonical Wnt signaling through sequestration of the β-catenin destruction complex inside multivesicular bodies (MVBs) and lysosomes. In this study, we introduce Ouabain, an inhibitor of the Na,K-ATPase pump that establishes electric potentials across membranes, as a potent inhibitor of Wnt signaling. We find that Na,K-ATPase levels are elevated in advanced colon carcinoma, that this enzyme is elevated in cancer cells with constitutively activated Wnt pathway and is activated by GSK3 inhibitors that increase macropinocytosis. Ouabain blocks macropinocytosis, which is an essential step in Wnt signaling, probably explaining the strong effects of Ouabain on this pathway. In Xenopus embryos, brief Ouabain treatment at the 32-cell stage, critical for the earliest Wnt signal in development-inhibited brains, could be reversed by treatment with Lithium chloride, a Wnt mimic. Inhibiting membrane trafficking may provide a way of targeting Wnt-driven cancers.

Funder

National Institutes of Health

University of California, Los Angeles Jonsson Comprehensive Cancer Center, the Norman Sprague Endowment for Molecular Oncology

SUNY Binghamton faculty startup fund

SUNY Binghamton TAE Seed Grant

Oklahoma University

Stephenson Cancer Center

OUHSC: The University of Oklahoma Health Sciences Center

Publisher

The Company of Biologists

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3